PTPRC and neoplasm: Additionally, to verify that tumor heterogeneity isn't altered by the enrichment, we assessed the expression of two cellular markers, EGFR and N‐Cadherin [27, 28], in the original MPE sample and compared it to the tumor cell‐enriched sample following two rounds of CD45+ cells depletion.